Canada • TSX Venture Exchange • TSX-V:THRM • CA8834262070
The current stock price of THRM.CA is 0.065 CAD. In the past month the price increased by 18.18%. In the past year, price decreased by -76.79%.
ChartMill assigns a technical rating of 3 / 10 to THRM.CA. When comparing the yearly performance of all stocks, THRM.CA is a bad performer in the overall market: 97.5% of all stocks are doing better.
ChartMill assigns a fundamental rating of 1 / 10 to THRM.CA. THRM.CA has a bad profitability rating. Also its financial health evaluation is rather negative.
Over the last trailing twelve months THRM.CA reported a non-GAAP Earnings per Share(EPS) of -0.07. The EPS decreased by -25.65% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -1021.89% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| PRN | PROFOUND MEDICAL CORP | N/A | 289.522M | ||
| TLT | THERALASE TECHNOLOGIES INC | N/A | 66.901M | ||
| MIR | MEDMIRA INC | N/A | 49.29M | ||
| CNVI | CONAVI MEDICAL CORP | N/A | 33.77M | ||
| PINK | PERIMETER MEDICAL IMAGING AI | N/A | 31.738M | ||
| ASG | AURORA SPINE CORP | N/A | 22.78M | ||
| VPT | VENTRIPOINT DIAGNOSTICS LTD | N/A | 20.124M | ||
| MDX | MEDX HEALTH CORP | N/A | 19.676M | ||
| NSCI | NANALYSIS SCIENTIFIC CORP | N/A | 17.946M |
View all stocks in the Health Care Equipment Industry | View all stocks in the Health Care Sector | View all stocks on the TSX Venture Exchange Exchange | Find stocks with similar TA and Setup ratings on the Canadian exchanges | Find stocks with similar Fundamental rating on the Canadian exchanges | Find the competitors with the best technical ratings on the Canadian exchanges | Find the competitors with the best fundamentals on the Canadian exchanges | Find the competitors with the best valuation on the Canadian exchanges | Find the competitors with the best dividend on the Canadian exchanges | Find the competitors with the best analyst ratings on the Canadian exchanges
Therma Bright, Inc. engages in developing and marketing skin care medical device products. The company is headquartered in Toronto, Ontario. The company went IPO on 2001-07-11. The firm is developing, acquiring, manufacturing and marketing proprietary healthcare and medical devices for the consumer and institutional marketplace focused on three key strategic areas: respiratory disease, vascular health and consumer medical devices. Its respiratory disease portfolio includes AI4LYF Digital Cough Technology and InStatin-novel inhaled treatment for asthma and COPD. Its vascular disease portfolio includes Inretio-ischemic stroke treatment and Venowave-Deep Vein Thrombosis Treatment Device (DVT). Its consumer health portfolio consists of AcuVid Covid-19 Rapid Antigen Saliva Test, Benepod-Contrast Therapy Device, TheroZAP-Thermal Therapy Device and InterceptCS-Cold Sore Prevention System. The firm holds trademarks for Therozap, InterceptCS and AcuVid.
THERMA BRIGHT INC
345 Danforth Avenue
TORONTO ONTARIO M4M 3P1 CA
CEO: Rob Fia
Employees: 0
Phone: 18442746837
Therma Bright, Inc. engages in developing and marketing skin care medical device products. The company is headquartered in Toronto, Ontario. The company went IPO on 2001-07-11. The firm is developing, acquiring, manufacturing and marketing proprietary healthcare and medical devices for the consumer and institutional marketplace focused on three key strategic areas: respiratory disease, vascular health and consumer medical devices. Its respiratory disease portfolio includes AI4LYF Digital Cough Technology and InStatin-novel inhaled treatment for asthma and COPD. Its vascular disease portfolio includes Inretio-ischemic stroke treatment and Venowave-Deep Vein Thrombosis Treatment Device (DVT). Its consumer health portfolio consists of AcuVid Covid-19 Rapid Antigen Saliva Test, Benepod-Contrast Therapy Device, TheroZAP-Thermal Therapy Device and InterceptCS-Cold Sore Prevention System. The firm holds trademarks for Therozap, InterceptCS and AcuVid.
The current stock price of THRM.CA is 0.065 CAD.
THRM.CA does not pay a dividend.
THRM.CA has a ChartMill Technical rating of 3 out of 10 and a ChartMill Fundamental rating of 1 out of 10.
THERMA BRIGHT INC (THRM.CA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.07).
You can find the ownership structure of THERMA BRIGHT INC (THRM.CA) on the Ownership tab.